As of 2026-03-20, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 14.8x | 13.9x |
| Forward P/E multiples | 15.7x - 20.4x | 18.2x |
| Fair Price | (19.11) - (17.99) | (19.56) |
| Upside | -183.0% - -178.2% | -185.0% |
| Date | EV/EBITDA |